Zynex Inc
NASDAQ:ZYXI
Intrinsic Value
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. [ Read More ]
The intrinsic value of one ZYXI stock under the Base Case scenario is 22.32 USD. Compared to the current market price of 11.78 USD, Zynex Inc is Undervalued by 47%.
Valuation Backtest
Zynex Inc
Run backtest to discover the historical profit from buying and selling ZYXI stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Zynex Inc
Current Assets | 87.9m |
Cash & Short-Term Investments | 44.6m |
Receivables | 26.8m |
Other Current Assets | 16.4m |
Non-Current Assets | 49m |
PP&E | 16.2m |
Intangibles | 28.6m |
Other Non-Current Assets | 4.3m |
Current Liabilities | 18.5m |
Accounts Payable | 8.4m |
Accrued Liabilities | 9.3m |
Other Current Liabilities | 829k |
Non-Current Liabilities | 72.2m |
Long-Term Debt | 58.1m |
Other Non-Current Liabilities | 14.2m |
Earnings Waterfall
Zynex Inc
Revenue
|
184.3m
USD
|
Cost of Revenue
|
-38m
USD
|
Gross Profit
|
146.3m
USD
|
Operating Expenses
|
-135.5m
USD
|
Operating Income
|
10.8m
USD
|
Other Expenses
|
-1m
USD
|
Net Income
|
9.7m
USD
|
Free Cash Flow Analysis
Zynex Inc
ZYXI Profitability Score
Profitability Due Diligence
Zynex Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
Zynex Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
ZYXI Solvency Score
Solvency Due Diligence
Zynex Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Score
Zynex Inc's solvency score is 71/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZYXI Price Targets Summary
Zynex Inc
According to Wall Street analysts, the average 1-year price target for ZYXI is 20.27 USD with a low forecast of 15.15 USD and a high forecast of 28.35 USD.
Ownership
ZYXI Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
ZYXI Price
Zynex Inc
Average Annual Return | 32.89% |
Standard Deviation of Annual Returns | 43% |
Max Drawdown | -80% |
Market Capitalization | 393.9m USD |
Shares Outstanding | 32 170 200 |
Percentage of Shares Shorted | 37.5% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. The company is headquartered in Englewood, Colorado and currently employs 774 full-time employees. The company went IPO on 2002-11-27. The Company’s devices are intended for pain management to reduce reliance on drugs and medications and provide rehabilitation and through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current (IFC), neuromuscular electrical stimulation (NMES) and transcutaneous electrical nerve stimulation (TENS). The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, and E-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream, Knee Braces and LSO Back Braces, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter. CM-1500 is a Zynex fluid monitoring system.
Contact
IPO
Employees
Officers
The intrinsic value of one ZYXI stock under the Base Case scenario is 22.32 USD.
Compared to the current market price of 11.78 USD, Zynex Inc is Undervalued by 47%.